Observations placeholder
Selegiline Eldepryl, Emsam and Zelapar
Identifier
001533
Type of Spiritual Experience
A description of the experience
Selegiline - L-deprenyl, Eldepryl , Emsam , Zelapar is a drug used for the treatment of early-stage Parkinson's disease, depression and senile dementia. In normal clinical doses it is a selective irreversible MAO-B inhibitor, however in larger doses it loses its specificity and also inhibits MAO-A.
Most common Selegiline hydrochloride side effects from eHealthme
- Hallucinations - (37 reports)
- Fall - (35 reports)
- Fever - (35 reports)
- Parkinson's disease - (34 reports)
- Agitation - (31 reports)
- Dyskinesia - (27 reports)
- Interstitial lung disease - (27 reports)
- Delirium - (26 reports)
- Hallucination, visual - (23 reports)
- Depressed level of consciousness - (23 reports)
Dietary restrictions are common for MAOI treatments, and dietary restrictions appear to be unnecessary at standard doses when selegiline is taken as Emsam, the transdermal patch form. Selegiline belongs to a class of drugs called phenethylamines. It is a methamphetamine derivative .
Most common Eldepryl side effects
- Pathological gambling - (68 reports)
- Obsessive-compulsive disorder - (44 reports)
- Emotional distress - (43 reports)
- Depression - (40 reports)
- Stress and anxiety - (35 reports)
- Confusion - (32 reports)
- Fatigue - (32 reports)
- Drug ineffective - (30 reports)
- Muscle rigidity - (28 reports)
- Road traffic accident - (26 reports)
On Feb, 02, 2017 511 people reported to have side effects when taking Selegiline Hydrochloride. Among them, 37 people (7.24%) have Hallucination
On Feb, 02, 2017 511 people reported to have side effects when taking Selegiline Hydrochloride. Among them, 7 people (1.37%) have Hallucination, Auditory
On Jan, 26, 2017 589 people reported to have side effects when taking Eldepryl. Among them, 10 people (1.7%) have Hallucination
On Feb, 02, 2017 589 people reported to have side effects when taking Eldepryl. Among them, 2 people (0.34%) have Hallucination, Auditory
On Feb, 02, 2017 1,193 people reported to have side effects when taking Emsam. Among them, 4 people (0.34%) have Hallucination
On Feb, 02, 2017 1,193 people reported to have side effects when taking Emsam. Among them, 2 people (0.17%) have Hallucination, Auditory
Time on Selegiline hydrochloride when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 20.00% | 40.00% | 20.00% | 20.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Selegiline hydrochloride :
Female | Male | |
Hallucination | 40.35% | 59.65% |
Age of people who have Hallucination when taking Selegiline hydrochloride :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 14.55% | 10.91% | 74.55% |
On Mar, 9, 2015: 545 people reported to have side effects when taking Selegiline hydrochloride. Among them, 14 people (2.57%) have Death.
Time on Selegiline hydrochloride when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 50.00% | 0.00% | 0.00% | 0.00% | 0.00% | 50.00% | 0.00% |
The source of the experience
eHealthmeConcepts, symbols and science items
Concepts
Symbols
Science Items
MAOIsActivities and commonsteps
Activities
Overloads
Alzheimers disease drugsAmphetamines and stimulants
Parkinsons disease drugs